Stefano Aliberti is Associate Professor in Respiratory Medicine at the University of Milan and Respiratory Consultant at the Policlinico University Hospital, Milan, Italy. He received his medical degree from the University of Milan and completed his clinical research training at the University of Louisville, KY, USA, working as member of the Community-Acquired Pneumonia Organization Database. Most of his research over the past fifteen years has been focused on both acute and chronic respiratory infections, and particularly on community-acquired pneumonia, bronchiectasis and non-tuberculous mycobacteria (NTM). He is former Head of the Respiratory Infections Assembly of the European Respiratory Society, chair of the European Registry of Bronchiectasis (EMBARC), the Italian Registry of Bronchiectasis (IRIDE) and the Italian Registry of pulmonary NTM (IRENE). He leads the Policlinico Bronchiectasis Program which includes a multidisciplinary team of physicians and respiratory physiotherapists taking care bronchiectasis, PCD and NTM patients at the Policlinico Hospital in Milan.

Peter Barnes is Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987. He has published >1000 peer-review papers on asthma, COPD and related topics (h-index 155) and has written or edited over 50 books. He is in the top 20 most highly cited researchers in the world and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He was President of the ERS in 2013/2014.
Read More >

Leif Bjermer, MD PhD,
Professor of Allergy and Asthma research
University of Lund, Sweden

Education
Medical school, Umeå University 1977-1986
Specialist in Lung Medicine 1987
Specialist in Allergology 2000

Position: 1992-2002 Professor and head of the department of lung medicine, University of
Trondheim, Norway.
From June 2002 – Professor at the dept of Respiratory Medicine and Allergology, University hospital
of Lund, Sweden.

Appointments: Chief Editor of Breath 2009-2012, Chief Editor of Respiratory Medicine 2002-9.
Chief Editor of ECRJ since 2014. Member of ATS, ACCP, ERS, EAACI. Chairman of EAACI
asthma section 2014-15     Read More >

Francesco Blasi, MD, FERS, is Professor of Respiratory Medicine and Head of the Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Cardiothoracic Unit IRCCS Fondazione Cà Granda Ospedale Maggiore Milan.
His research interests include the effects of atypical bacterial infection on cellular immunity in chronic bronchitis, and the role of atypical bacteria and viral infection in asthma onset.
He is also interested in the role of antibiotics in the treatment of chronic obstructive pulmonary disease (COPD) exacerbations and asthma. He is actively working on pneumonia and tuberculosis research trials.
Professor Blasi has published more than 230 papers in international journals.

Matteo Bradicich is a Research Fellow of the Respiratory Pathophysiology and Rehabilitation Unit at Cisanello University Hospital of Pisa (Italy). He also works as Data Manager for Severe Asthma Network Italy (SANI). He collaborates as Honorary Researcher with the Respiratory Medicine Unit of Nuffield Department of Medicine (University of Oxford, United Kingdom) as well. Having taken part to several clinical research and laboratory activities, his main research topics include the study of the pathophysiological pathways of asthma and its precision diagnostic and therapy strategies.

Fulvio Braido is Associate Professor of Respiratory Diseases Department at Dipartment Of Internal Medicine  –  University of Genoa, Italy. Graduated cum laude in 1993 at the School of Medicine, University of Genoa and Specialized  in Respiratory Diseases in 1997 and in Allergy and Clinical Immunology in 2006. He is the former Chairman of the CME Committee of European Academy of Allergy a Clinical Immunology  (EAACI) and the European Accreditation Board in Allergology and Clinical Immunology (EBAACI).  Read More >

Professor Giorgio Walter Canonica is Chairman of the Dept of Medical Specialties at the University Hospital S. Martino Genoa. He is also Director of the Allergy & Respiratory Diseases Clinic, Genoa University Italy a Galen Centre of Excellence. Professor Canonica initially specialised in pulmonary diseases after having received his medical degree from the University of Genoa, he then specialised in Allergy and Clinical Immunology at Florence University.
Professor Canonica’s research interests include examination of the molecular events and interactions between immunocompetent cells, inflammatory cells and epithelial cells in allergic inflammation and airway remodelling.

Mario Cazzola is Honorary Professor of Respiratory Medicine at the University of Rome Tor Vergata, Italy and Visiting Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK.

He is serving as Editor-in-chief of Pulmonary Pharmacology & Therapeutics and as an Associate Editor of Respiratory Medicine and Respiratory Research. He is a Section Head of Respiratory Pharmacology at F1000Prime, and a member of the Editorial Boards of Lancet Respiratory Medicine, Drugs, Respiration, COPD, International Journal of Chronic Obstructive Pulmonary Disease, and npj Primary Care Respiratory Medicine.

Prof. Cazzola is a fellow of the European Respiratory Society. He has received the 2015 European Respiratory Society Lifetime Achievement Assembly Award.

Prof. Stefano Centanni studied medicine at the School of Medicine of the University of Milan, where he received his Medical Doctor Degree in 1979. Following an internship at the pulmonary Division of the McMaster University, Hamilton, Canada, in 1981 and a fellowship at the Pulmonary Division of the Mount Sinai Medical Center at the University of Miami, Florida, USA, in 1982, he specialized in Allergology at the University of Medicine of Pavia, Italy, in 1985.
He received a PhD in Pulmonary Diseases in 1998 at the University of Milan Medical School.
From 1990 to 1996 he worked as Assistant Professor of the University of Milan at the Pulmonary Division of the Maggiore Hospital, Milan, and from 1996 to 2005 as Associate Professor at the Pulmonary Division of the San Paolo Hospital, University of Milan. Since 1996 he is Chief of the Pulmonary Division of the San Paolo Hospital, Milan, and in 2005 he became full professor of Respiratory Medicine at the University of Milan.
Professor Centanni was Italian National Delegate 2007/2009 at the ERS and FERS Italian National Delegate from 2007 until 2012 and President of SIMeR (Italian Society of Respiratory Medicine – 2009/2011). Professor Centanni is author of more than one hundred scientific publications in international journals and several book chapters and books in the field of Respiratory Medicine.

Professor James Chalmers is GSK/British Lung Foundation Professor of Respiratory Research and Honorary Consultant Respiratory Physician at the University of Dundee/Ninewells Hospital, Dundee.

His interests are in difficult airways disease, particularly bronchiectasis, COPD and severe asthma. He is chair of the European Bronchiectasis Registry (EMBARC) and chaired the recent European Bronchiectasis Guidelines. He is chair of the BTS Respiratory Infection SAG and is the incoming deputy chief editor of the European Respiratory Journal. In 2017 he won the Patrick Neil Medal from the Royal Society of Edinburgh and the Romain Pauwels award from the European Respiratory Society for his contribution to bronchiectasis research.

Fabiano Di Marco, pulmonologist working in Hospital San Paolo in Milan, is Associate Professor of the University of Milan. His primary research interests include lung pathophysiology, COPD, asthma, invasive and noninvasive mechanical ventilation. He has published more than 70 papers in international peer reviewed journals, and is an Associate Editor of BMC Pulmonary Medicine.

Isis E. Fernandez obtained her medical degree in Cartagena, Colombia. Her scientist career began at the Division of Pulmonary and Critical Care at Brigham and Women’s Hospital, and Harvard Medical School, Boston, USA in Prof. Rosas’ Lab. Later, she joined Comprehensive Pneumology Center in Munich, Germany and the lab of Lab of Prof. Eickelberg. She is currently serving as Section Editor of “basic science and experimental pulmonology” at BMC pulmonary medicine. Her scientific interest includes biomarker screening and the role of the immune system in Idiopathic Pulmonary Fibrosis.

Dr. Timm Greulich is presently a Senior Physician at the University Hospital Giessen and Marburg for Internal Medicine and Respiratory Diseases. He leads the laboratory for the diagnosis of Alpha-1- Antitrypsin-Defiency (AATD) at the University of Marburg. He attended his medical education at the Philipps-University Marburg, the Brethren College, North Manchester (Indiana, USA), and the University Hospital Singapore. He graduated from the University of Marburg and did his doctorial thesis at the Philipps-University Marburg, Germany. He began his career in Emergency Medicine and later went into Internal Medicine, Pulmonary Medicine, and Sleep Medicine. His research focuses on Alpha-1- Antitrypsin Deficiency (AATD) and other subtypes COPD and asthma. He is an active member of the Writing Committee for the National Guidelines for Asthma and has published numerous articles on COPD and AATD. Read more >

David F. Heigener is consultant in the department of thoracic oncology at the LungenClinic Grosshansdorf, -the largest lung cancer center in Northern Germanyand head of the palliative care team. His main interest is medical treatment of lung cancer. He participated in numerous trials in this field with about 100 publications and book contributions. Besides that, he is member of the palliative care task force in the German respiratory society and responsible physician for interventional bronchology in the department. David F. Heigener is Member of IASLC, ASCO, ESMO, German Respiratory Society (DGP), German Cancer Society (DKG) and German Society for Palliative Medicine (DGP). He is member of the Editorial Board of “Atemwegs- und Lungenkrankheiten” and Reviewer for “Lung Cancer”, “Respiratory Medicine”, “Annals of Oncology”, “British Medical Journal”, “Journal of Clinical Oncology” and “Journal of Thoracic Oncology” Read More >

Herth, Felix JF

Full Professor of Medicine, University of Heidelberg

CMO and CEO

Thoraxklinik-University of Heidelberg

Chairman and Head

Department of Pulmonology and Critical Care Medicine

Translational Lung Resaerch Center Heidelberg

Member of the German Lung Research Foundation (DZL)

Read More >

Dr. Michael Loebinger is a Consultant Respiratory Physician at the Royal Brompton Hospital with a specialist interest in respiratory infections, bronchiectasis and non-tuberculous mycobacteria (NTM).  He co-chairs the British Thoracic Society (BTS) bronchiectasis guideline committee and co-wrote the BTS NTM and European respiratory Society (ERS) bronchiectasis guidelines.  He is a founding member of the UK and European clinical and research bronchiectasis networks, and chairs the Embarc NTM registry.  He chaired the infection special advisory group for the BTS (2013-2016) and is secretary of the ERS respiratory infection group. He also holds an honorary senior lecturer position at Imperial College and supervises PhD, MSc and medical students.
Read More>

• Pulmonologist at Hospital Universitario Virgen del Rocío, Seville, Spain, in charge of a monographic COPD and bronchiectasis outpatient clinic.
• Associate Professor of Medicine at Seville’s University.
• Tutor of residents of Pneumology at Hospital Universitario Virgen del Rocío, Seville, Spain.
• Head of a research group linked to the CIBER of Respiratory Diseases, Ministry of Economy, Spain

Read More >

Fabrizio Luppi is Chairman of the “Centre for Rare Lung Diseases” and Consultant at the Department of Respiratory Diseases at the University Hospital of Modena. He received his medical degree from the University of Modena in 1993. Then, he spent part of his PhD program at the Department of Pulmonology of the University of Leiden (The Netherlands) working on epithelial cell involvement in smoking-induced lung diseases.
He has been the Principal Investigator of several phase II and III trials on idiopathic pulmonary fibrosis and his primary research interest includes interstitial lung diseases, particularly idiopathic pulmonary fibrosis and sarcoidosis. He has published more than 50 papers in international peer reviewed journals, and he is an Associate Editor of BioMedical Research International: Pulmonology.

• University of Florence, Professor of Respiratory Medicine (1997 – )
• Head of the Thoracic Section of the Cardiothoracic and vascular Department Careggi University Hospital, Florence (2014 – )
• University of Pisa, Associate Professor of Respiratory Pathophysiology (1991 -1996)
• University of Rome “Tor Vergata”, Associate Professor of Respiratory Pathophysiology (1988-1991)
• National Research Council ( CNR) Institute of Clinical Physiology, Pisa , Career Investigator (1975- 1987)
• Euratom fellowship, CNR Institute of Clinical Physiology, Pisa  

Read More >

Doctor of Medicine in Cardiopulmonary Pathophysiology from the University of Pisa (Italy). Specialist in respiratory medicine she is involved in the field of respiratory infections and particularly in Community Acquired Pneumonia (CAP), noncystic fibrosis bronchiectasis (NCFB) and humoral immuno-deficiencies. She investigates epidemiology, risk factors, outcome, treatment and prevention of the most relevant respiratory infections. In the field of bronchiectasis she has been investigating the microbiological causes of exacerbations (pneumonia and simple exacerbations) and the application of respiratory physiotherapy to improve airways clearance and fatigue in this chronic and debilitating disease. Despite the enormous advances in antibiotic therapy CAP is still a very prevalent disease worldwide with a considerable morbidity and mortality. Main efforts of the projects she carries on in this line of research are directed at monitoring epidemiological and clinical changes of the disease and evaluating strategies of better disease control and prevention with special attention to some risk classes of patients such as elderly and long term care facility residents (Healthcare associated pneumonia, HCAP). In the field of bronchiectasis main objectives are focused on investigation of the prevalence and outcomes of this under estimated but very frequent disease and its impact on the society. In particular the real prevalence and clinical endpoints of NCFB (i.e. quality of life, chronic expectoration) in the general population are still unclear although there are data suggesting that the disease could be as prevalent as COPD. Humoral immuno-deficiencies are part of a group of rare immunological disorders causing recurrent respiratory infections whose genetics is still barely known. In this line new therapeutic approaches are tested and several collaboration projects with other institutions are carried out to broaden our knowledge about immunological and genetic disorders possibly involved in the disease. In summary, the results of her research are aimed at investigating pathogenetic mechanisms of respiratory infections, improving their clinical outcomes and patients’ quality of life.  Read More >

Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL). His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.

Nicolas Roche is Professor of Respiratory Medicine at Cochin Hospital, University of Paris Descartes, Paris, France. He graduated in medicine in 1994 and obtained his PhD in 2003. He spent a year as a research fellow at Imperial College London, London, UK. His major areas of interest are chronic obstructive pulmonary disease (COPD), asthma, inhaled therapy and real-life research.

Professor Roche coordinates epidemiological research projects as well as a dedicated nationwide clinical research group. His clinical research topics include the study of disease phenotypes, the development of new clinical assessment tools and the evaluation of treatment strategies for COPD and asthma.

He is involved in national public health initiatives on COPD. He participated in the development of French guidelines on asthma and education of asthmatic adults, coordinates the French guidelines on COPD. He is a member of the Global Initiative on Obstructive Lung Disease science committee and the executive committee of the Respiratory Effectiveness Group.

Professor Roche has authored more than 250 articles in international peer-reviewed journals and edited or co-edited several books on COPD, including articles on inhalation therapy for asthma and COPD. He is Vice-President of Société de Pneumologie de Langue Française, member of the Clinical Research Collaboration working group of the European Respiratory Society and member of the American Thoracic Society. He has been Chief Editor of Revue des Maladies Respiratoires, and is Associate Editor of the European Respiratory Review and the Clinical Respiratory Journal.

Dermot Ryan is a recently retired GP from the UK. He has had a long standing interest in Primary Care Respiratory Disease and Allergy. He established the Primary Care professorial unit at the University of Aberdeen and was instrumental in the foundation of the journal npjPrimary Care Respiratory Medicine. He has latterly been the chair of the Primary Care Interest Group of the European Academy of Allergy and Clinical Immunology where ie was actively involved in the creation of the recent AIT guidelines. He is currently an Honorary Clinical Research Fellow at the University of Edinburgh and President of the Respiratory Effectiveness Group.

Pierachille Santus is currently Associate Professor in Respiratory Medicine at the University of Milano, Italy and Head of Respiratory Division at “L. Sacco” University Hospital-ASST Fatebenefratelli Sacco Milano, Italy.

He graduated in 1996 at the School of Medicine, University of Milano and participated to the Residence Programme in Respiratory Diseases in the period 1996-2000 at the same University. Prof. Santus obtained his Ph.D on Molecular Biology-Curricula Molecular Oncology at the University of Milano, Italy in 2004. In the 2001, Prof. Santus was a post-doctoral research fellow at the Aintree Chest Centre – University Aintree Hospital NHS, Fazakerly Hospital with Prof. P.M.A. Calverley MD (Liverpool-UK) and during the summer fellow at the Biomedical Engineering Centre of Boston University with Prof. K. Lutchen PhD (Boston-USA).

Prof. Santus work in a clinical setting managing all the acute and chronic respiratory diseases in terms of diagnosis (noninvasive and invasive technics) and therapy (eg noninvasive ventilation, biological and innovative drugs).  

He is principal investigator in clinical studies and international RCTs focused on COPD and asthma innovative treatment, and his main research interests are the clinical aspects of COPD and asthma, with special focus on the physiological and pathophysiological modifications that affected the lung mechanics, airways variability of subjects affected by chronic respiratory diseases. However, Prof. Santus have research interest also on the clinical pharmacology in COPD and Asthma, with particular focus on the molecular and pathophysiological modification related to bronchodilators.

Prof. Santus has an excellent experience, as principal investigators, in National and International clinical trials according to Good Clinical Practice. He is heavily engaged in teaching activities for the School of Medicine, Rehabilitation and Extracorporeal Cardiac Technicians in the University of Milano, where he teaches Respiratory Diseases.

He is member of the European Respiratory Society, the Italian Respiratory Society (head of the working group on chronicity and general management of respiratory diseases).

He is author of seventy-two peer-reviewed publications and co-author of several book chapters and monographs. Prof. Santus served as reviewer for many respiratory journals and he is Section Editor (Pulmunology) of the European Journal of Internal Medicine.

Nicola Scichilone is currently Associate Professor in Respiratory Diseases of the Department of Biomedicine and Specialistic Medicine, University of Palermo, Italy, and Adjunct Associate Professor of the Department of Environmental Health Science of the Johns Hopkins University, Baltimore, USA.

Dr. Scichilone is active staff of the “V. Cervello” Hospital in Palermo, where he is head of the Outpatient Clinics of Allergy and of Asthma and Respiratory Diseases. He graduated cum laude in 1992 at the School of Medicine, University of Palermo and participated to the Residence Programme in Respiratory Diseases in the period 1994-1998 at the same University.

From 1998 to 2001, Dr. Scichilone was a post-doctoral research fellow at the Asthma and Allergy Center of the Division of Allergy and Immunology of the Johns Hopkins University in Baltimore, and since then, he has maintained active scientific collaborations with the Institution, as a consultant for NIH grants at the Johns Hopkins University. Dr. Scichilone obtained his Ph.D on Respiratory Physiopathology at the University of Parma, Italy in 2004. He is principal investigator in clinical studies performed at the Department of Biomedicine and Specialistic Medicine in Palermo, and his main research interests are the pathogenesis of airway hyperresponsiveness and the clinical aspects of asthma and COPD.

Dr. Scichilone has an excellent experience in clinical trials according to Good Clinical Practice. He is heavily engaged in teaching activities for the School of Medicine in Palermo, where he teaches Respiratory Diseases. He is member of the European Respiratory Society, the Italian Society of the Aerobiology, the Italian Respiratory Society, the Italian Society of Allergy, Asthma and Immunology, and the Italian Society of Respiratory Diseases in Geriatric Age. He is author of more than one-hunfred peer-reviewed publications and co-author of several book chapters and monographs.

Dave Singh is Professor of Respiratory Pharmacology at the University of Manchester. He graduated from Cambridge University and went on to train in medicine and clinical pharmacology in Manchester, which included working in industry on early phase clinical trials. His research interests are in the pharmacotherapy of Asthma and COPD, with studies spanning from basic pharmacology of anti-inflammatory drugs to clinical trials.
He has acted as Principal Investigator on numerous clinical trials of novel therapies in asthma and COPD, and has over 200 publications in peer reviewed journals. He is a member of the GOLD Science Committee.

1996-1997: Medical Degree (110/110 cum laude);
2000-2001: Specialization in Infectious Diseases (50/50 cum laude);
2003-2004: PhD in “Methodology of Clinical Trials” (Excellent);
2006-2007: Specialization in Medical Statistics (50/50 cum laude).
2014-2015: Executive Master in Management of Health and Social Care Organizations.
2016: Fellow of European Respiratory Society (FERS)
Read More >

Medical degree at the University of Bologna (2002)
Registrar in Radiology at the Academic Hospital of Parma (2002-2006)
PhD in “Advanced Cardio-Thoracic Imaging” at the University of Parma (2007-2010)
Research collaborator at the Royal Brompton Hospital of London (since 2005 )
Visitor at the Department of Radiology of the Vancouver General Hospital (May-June 2007)
Research collaboration at the National Cancer Institute of Milan for the lung cancer screening
project “Multicentric Italian Lung Detection” trial (since 2007)
Lecturer/Consultant at the University Hospital of Parma (2010-2014).
Associate Professor/Consultant at the University Hospital of Parma (2014 – )
Read More >

Born in Barcelona in 1954, he is Full Professor in Medicine (Pulmonology) at the University of Barcelona (UB) and Director of the Respiratory Intensive Care Unit at Hospital Clínic. He is considered a physician of reference both nationally and internationally in lung infections, chronic obstructive pulmonary disease , bronchiectasis, weaning of mechanical ventilation and acute respiratory distress syndrome (ARDS-ALI). He leads the research group on Applied Research in Respiratory Diseases of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), from where he facilitates translational research studies. He also coordinates a CIBER group on respiratory diseases (Ciberes), an SGR (Generalitat de Catalonia) group and participates in several European projects. He is author of more than 1200 scientific publications and has supervised 34 Phd theses. He has a Hirsch index of 94. Several clinical key findings of his group have been translated to clinical practice.

J .Christian Virchow, MD, FRCP, FCCP, FAAAAI, is a Professor of Medicine and Pneumology and Head of the Departments of Pulmonary Medicine and Intensive Care Medicine in the University Medical Clinic at the University of Rostock, Germany. He is also the Medical Director of the Pulmonary Diagnostic Services and the Sleep Laboratory of the University of Rostock. He is Editor-in-Chief of RESPIRATORY MEDICINE and Visiting Professor of the China-Japan-friendship hospital in Beijing, PR China. He is a member of several medical organizations, including the American Thoracic Society, the European Respiratory Society, and the American College of Chest Physicians. Dr. Virchow serves as Associate Editor for several German journals in pulmonology and allergology and has served as an ad hoc reviewer for Chest, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the European Respiratory Journal and many others. He is the author or coauthor of more than 200 peer reviewed articles for journals such as JAMA, the American Journal of Respiratory and Critical Care Medicine, Chest, and European Respiratory Journal and author of several chapters for text books. He received his doctoral degree from the University of Tübingen, Germany after attending Medical School in Marburg and Giessen, Germany and Zürich, Switzerland. Dr. Virchow completed his residency in internal medicine at University Medical Clinic in Freiburg, Germany, and his fellowship in pulmonary medicine at the Department of Pneumology at the University of Freiburg, Germany under Prof. H. Matthys. His special interests are research into the mechanisms of inflammation in chronic obstructive lung diseases such as asthma and COPD as well as the treatment of these conditions.

Prof. Dr. med. Jens Vogel-Claussen

• Since 3/2011: Vice-Chairman, Institut für Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover;
• Since 3/2011: Section Chief der Cardiothoracic Imaging and MRI Institut für Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover;
• 1/2010-2/2011: faculty, Diagnostische Radiologie, Eberhard-Karls-Universität Tübingen;
• 10/2009-12/2009: junior faculty, Diagnostische Radiologie, Eberhard-Karls-Universität Tübingen;
• 7/07-10/2009: Assistant Professor of Radiology, Faculty Cardiovascular and Body Imaging, Johns Hopkins University School of Medicine, USA;
• 7/06-6/07: RSNA Fellowship Cardiovascular Imaging / Body MRI, Johns Hopkins University School of Medicine, USA;
• 7/02-6/06: Radiology residency, Johns Hopkins University School of Medicine, USA;
• 7/01-6/02: Medicine Internship, Broomfield Hospital, Chelmsford, UK.

Read More >

Professor Tobias Welte is the Head of the Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover.
1978 -1985: Study of human medicine, Hannover Medical School
1985 – 88/90: Department of Internal Medicine, County Hospital Lehrte
1989: Residentialship, Massuchusetts General Hospital Boston, USA
1990-1994: Fellow, Department of Respiratory Medicine, Hannover Medical School
1992: Specialist for Internal Medicine
1994: Specialist for Respiratory Medicine
1994: MD
1995: Specialist Intensive Care Medicine
2000: Habilitation for “Internal Medicine”
2002: Specialist for Infectious Disease Academic Appointments:
1994 – 2004 : Head of the Division of Respiratory Medicine and Intensive Care, University of Magdeburg
2003: Appointment C3 Professorship for Respiratory Medicine University of Magdeburg, not accepted
since 2004: W3-Professorship, Head of the Department of Respiratory Medicine, Hannover Medical School
2015: Appointment Professorship for Pneumology, University of Vienna, not accepted Other (selected) Professional Activities:
1994 – today: Project leader in more than thirty research projects funded by DFG, BMBF and EU
Since 2001: Co-ordinating board of BMBF-competence networks PROGRESS, ASCONET and CAPNETZ as well as Chairman of CAPNETZ Foundation
2007-2011: Speaker of the BMBF funded Clinical Study Center Hannover (KS-MHH)
since 2011: Member of the board of directors of the German Center for Lung Research (DZL) and director of the Hannover DZL site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease Hannover)
since 2011: Member of the Internal Advisory Board of the German Center of Infectious Disease Research (DZIF)
2008-2010: President of the German Society of Medical Intensive Care Medicine
2009-2015: Chief Editor of the European Respiratory Monograph
since 2008: Member, since 2012 Spokesman of DFG-Fachkollegium “Inflammation”
2009-2013: President of the German Sepsis Society
2012-2014 President of German Society of Pneumology
Additional Information: 2014 Appointment as Fellow of the European Respiratory Society (FERS)